Keywords: two-year, data, support, xenical, efficacy, new, study

Two-year data support Xenical's efficacy

Article | 21 January 1999

Print This

A new US study of Roche's lipase inhibitor for the treatment of obesity,Xenical (orlistat), has revealed that the drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in